1- D'Haese PC, Clement JP, ELseviers MM, Lamberts LV, VAN de Vyver FL,Visser WJ, De broe ME. Value of serum aluminium monitoring in dialysis patients: a multicentre study. Nephrol Dial Transplant 1990;5:45-53.
2- Casti S, Campise M, Ponticelli C. Aluminium interference in the treatment with recombinant human erythropoietin. Contrib Nephrol 1990;87-94.
3- Muirhead N, Hodsman AB, Hollomby DJ, Cordy PE. THE role of aluminium and parathyroid hormone in erythropoietin resistance in haemodialysis patients.Nephrol Dial Transplant 1991;6:342-345.
4- Bia MJ, Cooper K.SCHnall S, Duffy T, Hendler E, Maqlluche H, Solomon L. Aluminium induced anemia:pathogenesis and treatment in patients on chronic hemodialysis. Kidney Int 1989;3 6:852-858.
5- Abreo K, Glass J. Cellular, biochemical, and molecular mechanisms of aluminium toxicity. Nephrol dial Transplant 1993;Suppl 1:5-11. v 6-Chazan JA, Lew NL, Lowrie EG. Increased serum aluminium. Arch Intern Med 1991;151:319-322.
7- Consensus conference.Diagnosis and treatment of aluminium overload in end-stage renal failure patients. Nephrol Dial Transplant 1993;Suppl 1:1-4.
8- Cannata AB, Lopez JBD. Insights into the complex aluminium and iron relationship . Nephrol Dial Transplant 1991;6:605-607.
9- Ittel TH. Determinants of gastrointestinal absorption and distribution of aluminium in health and uremia. Nephrol Dial Transplant 1993;Suppl 1:17-24.
10-Eschbach JW.EgrieJC, Dowing MR, Browne JK, Adamson JW. Correction of the anemia of end stage renal disease with recombinant human erythropoietin; results of a combined phase I and II clinical trial.N Engl J Med 1987;310:73-78.
11- Horl WH, dreyling K, Steinhauer HB, Engelhardt R,
Schollmeyer P. Iron status on dialysis patients under rhuEPO
therapy. Contrib Nephrol 1990;87:78-86.
12- Lugowski S, Smith DC, VAN Loon JC. THE determination of Al,Cr,Co,Fe and Ni in whole blood by electrothermal atomic
57
absorption spectrophotometry. J Biomedical Materials Research 1987; 21:657-74.
13- Trapp GA. Plasma aluminium is bound to transferrin. Life Sci 1983;33:311-316.
14- Ittel TH, Schulpin A, Sieberth HG.Relationship between body iron Stores and intestinal absorbtion of aluminium
(absract). Nephrol Dial Transplant 1991;6:817.
15- Ittel TH, Schulpin A.Sieberth HG. Body iron stores donot affect the enchanced intestinal absorption of aluminium in uremia(abstact). J Am Soc Nephrol 1991;2:611.
16- Cannata JB, Suarez C, Cuesta MV, Rodriguez RR, Ailende MT, Herrera J,Perez Llanderal J. Gastrointestinal aluminium absorbtion:is it modulated by the iron-absorptive mechanism
Proc Eur Dial Transplant Assoc 1984:21:354-359.
17- Abreo K, Glass J, Sella ML. Aluminium inhibits hemoglobin synthesis but enhances iron uptake in Friend erytholeukemia cells. Kidney Int 1990;37:677-681.
18- Fernandez Menendez MJ, Fell GS, Brock JH, Cannata JB.
Aluminium uptake by intestinal cells.Effect of iron status and precomplexation. Nephrol Dial Transplant 1991;6:672-674.
19- Cannata JB,Olaizola In, Gomez- Alonso C, Menendez-Fraga p, Alonso- Suarez M,Diaz-Lopez JB. Serum aluminium transport and aluminium uptake in chronic renal failure :role of iron and aluminium metabolism. Nephron 1993;65:141-146.
20- Vanuytsel JL, D'Haese PC, Couttenye MM, DE Broe ME. Highe serum aluminium concentrations in iron-depleted dialysis patients.Nephrol DialTransplant 1992;7:177.
21- Huang YY, Huang CC, Lum PS, Wu MS.Leu ML. Effect of body iron stores on serum aluminium level in hemodialysis
patients. Nephron 1992;61:158-162.
22- Hosokawa S, Yoshida O. Effects of erythropoietin on trace elements in patients with chronic renal failure undergoing
hemodialysis. Nephron 1993;65:414-417.
23- Van de Vyver FL, Vanheulle AA, Majelyne WM et al. Serum ferritin as a guide for iron stores in chronic hemodialysis patients. Kidney international 1984;26:451-458.
58
Thank you for copying data from http://www.arastirmax.com
